Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
As of today, Eli Lilly(LLY) shares are valued at $1,070.01. The company's market cap stands at 1.01T, with a P/E ratio of 53.27 and a dividend yield of 55.7%.
On 2026-01-14, Eli Lilly(LLY) stock moved within a range of $1,061.12 to $1,084.00. With shares now at $1,070.01, the stock is trading +0.8% above its intraday low and -1.3% below the session's peak.
Trading volume for Eli Lilly(LLY) stock has reached 1.91M, versus its average volume of 2.77M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
LLY News
Key Points Eli Lilly's weight-loss drugs are experiencing rapid growth. It still has a long way to go to help curb obesity rates around the globe. The stock...
NVIDIA Corp.’s (NASDAQ:NVDA) and Eli Lilly and Co.'s (NYSE:LLY) newly announced $1 billion AI co-innovation lab underscores how artificial intelligence is sprea...
Plenty of growth lies ahead for these top healthcare companies. What makes a winning healthcare stock? One that is a leader in its industry and has proven its...
Analyst ratings
79%
of 29 ratingsMore LLY News
BMO Capital Markets (BMO) is pounding the table on Eli Lilly’s (LLY) stock to begin the new year. Claim 70% Off TipRanks Premium The brokerage firm has reiter...
Key Points Eli Lilly leads in the GLP-1 drug space with its shot-based offerings Mounjaro and Zepbound. Rival drugmaker Novo Nordisk has now introduced a pill...
Evan Seigerman, an analyst from BMO Capital, maintained the Buy rating on Eli Lilly & Co. The associated price target remains the same with $1,200.00. Claim 70%...
The Government of France has shot down rumors that U.S. pharmaceutical giant Eli Lilly (LLY) is planning to acquire French biotech firm Abivax (FR:ABVX) for $17...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Claim 70% Off TipRanks Premium Eli Lilly is advancing its mental health pipel...
Nvidia Corp (NASDAQ:NVDA) and Eli Lilly and Co (NYSE:LLY) are launching a lab designed to apply advanced artificial intelligence to drug development. The colla...
...
